Home / Private raises / Linnaeus Therapeutics, Inc.

Linnaeus Therapeutics, Inc.

Biotechnology · Haddonfield, New Jersey · $3.7M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-18D (new)$3.7M$10.0M4506(b)EquityNov 16SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedHaddonfield, New Jersey
EntityCorporation
IncorporatedDelaware
Minimum investment$1
SEC CIK1752026

People named in the latest filing

NameRole
Patrick MooneyDirector
Chris ArendtDirector
Michael PoiselDirector
Todd ThomsonDirector
James 30 Washington Avenue, Suite FDirector
John LeppingDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?